Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hippeas is a private snack food company and consumer brand best known for plant-based chickpea and yellow-pea snacks, including puffs, chips, and pops. The brand positions itself around better-for-you and sustainability attributes such as vegan, gluten-free, and non-GMO formulations, and emphasizes the environmental benefits of legume-based ingredients. Hippeas operates commercially rather than as a biotech or healthcare company, selling packaged snacks through retail and e-commerce channels. The business is associated with Green Park Snacks/Green Park Brands and has raised outside funding from consumer-focused investors including The Craftory, CAVU Venture Partners, and Strand Equity Partners. As of 2026, Hippeas remains an active private company/brand and is not a life sciences, biotech, pharma, or healthcare therapeutics company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Hippeas.